A randomised double-blind study to compare two regimens of Levonorgestrel in emergency contraception in Nigeria

ISRCTN ISRCTN69287540
DOI https://doi.org/10.1186/ISRCTN69287540
Secondary identifying numbers WHO/HRP ID: A15062
Submission date
19/03/2004
Registration date
01/04/2004
Last edited
09/02/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr D Chikamata
Scientific

World Health Organization
20 Avenue Appia
Geneva
CH-1211
Switzerland

Email chikamatad@who.int

Study information

Study designMulticentre controlled randomised double-blind two-arm clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typePrevention
Scientific title
Study objectivesCompare two regimens of levonorgestrel for emergency contraception in seven centres in Nigeria.
Ethics approval(s)Not provided at time of registration.
Health condition(s) or problem(s) studiedContraception
Intervention1. Levonorgestrel two doses of 0.75 mg 12 hours apart
2. Levonorgestrel one dose of 1.5 mg
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Levonorgestrel
Primary outcome measureEfficacy, side-effects and timing of next menstrual period at six weeks.
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/08/2002
Completion date01/08/2004

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants3150 total, 450 per centre, 1575 per group
Key inclusion criteria1. Requesting emergency contraception within 120 hours of unprotected intercourse
2. Only one act of unprotected intercourse during current cycle
3. Willing to abstain from further acts during current cycle
4. Regular menstrual cycles (24 to 42 days)
5. Having at least one spontaneous cycle before current cycle
6. Available for follow-up in the next six weeks
7. Negative pregnancy test
8. Willing to participate
9. Not breastfeeding
10. No use of hormonal contraceptives or of rhythm or natural family planning method of contraception during current cycle
11. Not unsure about the date of last menstrual period
Key exclusion criteriaDoes not comply with the above inclusion criteria.
Date of first enrolment01/08/2002
Date of final enrolment01/08/2004

Locations

Countries of recruitment

  • Nigeria
  • Switzerland

Study participating centre

World Health Organization
Geneva
CH-1211
Switzerland

Sponsor information

World Health Organization (WHO) (Switzerland)
Research organisation

20 Avenue Appia
Geneva
CH-1211
Switzerland

Website http://www.who.int/en/
ROR logo "ROR" https://ror.org/01f80g185

Funders

Funder type

Research organisation

World Health Organization (WHO) (Switzerland)
Private sector organisation / International organizations
Alternative name(s)
منظمة الصحة العالمية, 世界卫生组织, Всемирная организация здравоохранения, Organisation mondiale de la Santé, Organización Mundial de la Salud, WHO, 世卫组织, ВОЗ, OMS
Location
Switzerland

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2002 Yes No
Results article results 01/10/2010 Yes No